» Articles » PMID: 1713742

Cell-surface Ganglioside GD2 in the Immunohistochemical Detection and Differential Diagnosis of Neuroblastoma

Overview
Specialty Pathology
Date 1991 Aug 1
PMID 1713742
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The expression of the disialoganglioside GD2 was analyzed in 67 solid tumors and normal tissues from children by using the GD2-specific murine monoclonal antibody 3A7 and the indirect immunoperoxidase method. GD2 was expressed in all of 28 neuroblastomas and was most abundant in stroma-poor tumors. In differentiating stroma-rich neuroblastomas, neuroblastic clusters, neurofibrils, and most ganglion-like cells were positive, whereas Schwann's-cell stroma did not express GD2. In ganglioneuromas, only a few ganglion-like cells showed GD2, whereas all other structures were negative. Scattered foci of ganglioside GD2 also were found in some non-neuronal tumors, such as rhabdomyosarcomas and osteosarcomas, but not in lymphomas, Askin tumors, or most Wilms' tumors. The monoclonal antibody 3A7 is a useful aid in the immunohistochemical diagnosis of neuroblastoma. In addition, the intense cell surface staining of neuroblastoma cells by this reagent makes it potentially useful for detecting residual neuroblastoma in bone marrow samples and lymph node biopsies.

Citing Articles

Generation of Functional and Mature Sympathetic Neurons from Human Pluripotent Stem Cells via a Neuroepithelial Route.

Fan Y, Huang S, Li F, Zhang X, Huang X, Li W J Mol Neurosci. 2024; 74(1):19.

PMID: 38358571 DOI: 10.1007/s12031-024-02196-5.


Targeting solid tumor antigens with chimeric receptors: cancer biology meets synthetic immunology.

Kembuan G, Kim J, Maus M, Jan M Trends Cancer. 2024; 10(4):312-331.

PMID: 38355356 PMC: 11006585. DOI: 10.1016/j.trecan.2024.01.003.


Biology of GD2 ganglioside: implications for cancer immunotherapy.

Machy P, Mortier E, Birkle S Front Pharmacol. 2023; 14:1249929.

PMID: 37670947 PMC: 10475612. DOI: 10.3389/fphar.2023.1249929.


Evaluation of Potential Targets for Fluorescence-Guided Surgery in Pediatric Ewing Sarcoma: A Preclinical Proof-of-Concept Study.

Jeremiasse B, Rijs Z, Angoelal K, Hiemcke-Jiwa L, de Boed E, Kuppen P Cancers (Basel). 2023; 15(15).

PMID: 37568714 PMC: 10417270. DOI: 10.3390/cancers15153896.


The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of .

Pilgrim A, Jonus H, Ho A, Cole A, Shim J, Goldsmith K Oncoimmunology. 2023; 12(1):2240678.

PMID: 37554309 PMC: 10405770. DOI: 10.1080/2162402X.2023.2240678.